Talaris Therapeutics Announces Closing of Initial Public Offering
11 mai 2021 16h01 HE
|
Talaris Therapeutics, Inc.
BOSTON and LOUISVILLE, Ky. , May 11, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to...
Talaris Therapeutics Announces Pricing of Initial Public Offering
06 mai 2021 21h53 HE
|
Talaris Therapeutics, Inc.
BOSTON and LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing therapies with the potential to transform the standard...
Longboard Pharmaceuticals Announces Pricing of Initial Public Offering
11 mars 2021 21h44 HE
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological...